Previously, phosphonic acid derivatives of calix [4]arene and thiacalix [4]arene were found to be potential inhibitors of protein tyrosine phosphatase 1B. In the present paper, the inhibitory activity 
This enzyme may also be responsible for insulin signaling and glucose homeostasis in dietinduced obese mice [11] . Therefore, a possibility to control the activity of the PTPs may decrease risk of developing the pathologies. This demands more effective and selective inhibitors of PTPs to create new therapeutics [12, 13] .
Calix [4] arenes represent macrocyclic three-dimensional molecules which are widely studied for their applications in bioorganic chemistry and medicine [14] [15] [16] [17] . Some of calix [4] arene derivatives have low toxicity [17] [18] [19] and were found to exhibit antibacterial [20, 21] , antiviral [22, 23] , and anticancer activities [24, 25] . These compounds can also be useful for biochemical recognition and separation of amino acids, nucleotides, carbohydrates, and steroids [26] . Figure 1 ) were synthesized according to the previously developed protocols [33] [34] [35] . 
Results and discussion
The data presented in Figure It is known that active site of PTP is highly conserved. To accommodate a substrate, the active surface should carry a positive charge and provide hydrophobic environment [41] . As compared to macrocycles 1 and 2, Table 1 ).
The complex of compound 3 with MEG2 ( Fig.   3A) showed that OH-groups at the lower rim interact with Lys411 and Arg521, while sulfonyl groups form H-bonds with Tyr333, Trp468, Lys411, Ser516, Ala517, Gly520, and Arg521. The inhibitor takes part in aromaticaromatic interaction with Tyr333 and aromaticcation interaction with Arg409 and Arg521. In addition, hydrophobic contacts were observed with Ala517, Ile519, and Tyr471. At the same time, the ligand located at the active site of PTP1B (Fig. 3B) Protein tyrosine phosphatases in the human genome. Cell.
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